Literature DB >> 6275071

Multiple receptor types for octopamine in the locust.

P D Evans.   

Abstract

1. Three different pharmacological classes of octopamine receptor mediate the actions of octopamine on the locust extensor-tibiae neuromuscular preparation. A receptor classification scheme is proposed based on the results of detailed studies with agonists and antagonists. 2. Octopamine1 class receptors mediate the slowing of a myogenic rhythm found in a specialized proximal bundle of muscle fibres. Octopamine2A class receptors mediate the increase in amplitude of slow motoneurone twitch tension and octopamine2B class receptors mediate the increase in relaxation rate of twitch tension induced by firing either the fast or the slow motoneurones. 3. Octopamine1 receptors can be distinguished from the 2A and 2B classes since chlorpromazine (and yohimbine) are much better blocking agents than metoclopramide at the former receptors, whereas the converse is true for the latter class. Also clonidine is a more effective agonist than naphazoline for the former receptors and the converse is true for the latter class. 4. Octopamine 2A can be distinguished for octopamine 2B receptors since metoclopramide, mianserin and cyproheptadine show a strong preference for blocking the former class. Also naphazoline is a much better agonist than tolazoline at the former receptors and tolazoline is a much better agonist than clonidine at a latter. 5. The results are discussed in terms of the location of the various classes of octopamine receptors, their possible relationship to vertebrate alpha-adrenoreceptors, and the significance of the results for studies on octopamine receptors in the vertebrate central nervous system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275071      PMCID: PMC1245480          DOI: 10.1113/jphysiol.1981.sp013853

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  28 in total

1.  Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.

Authors:  P Jenner; C D Marsden; E Peringer
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Identification of octopamine as l-p-hydroxyphenylethanolamine.

Authors:  V ERSPAMER
Journal:  Nature       Date:  1952-03-01       Impact factor: 49.962

3.  Neural mechanisms underlying behavior in the locust Schistocerca gregaria. I. Physiology of identified motorneurons in the metathoracic ganglion.

Authors:  G Hoyle; M Burrows
Journal:  J Neurobiol       Date:  1973

4.  Evidence that insect dorsal unpaired medican (DUM) neurons are octopaminergic.

Authors:  G Hoyle
Journal:  J Exp Zool       Date:  1975-09

5.  Effect of cyproheptadine on the octopamine-induced responses in the mammalian central nervous system.

Authors:  W P Dao; R J Walker
Journal:  Experientia       Date:  1980-05-15

6.  Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding.

Authors:  L T Williams; D Mullikin; R J Lefkowitz
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

7.  The association of octopamine with specific neurones along lobster nerve trunks.

Authors:  P D Evans; E A Kravitz; B R Talamo; B G Wallace
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

8.  Octopamine: presence in firefly lantern suggests a transmitter role.

Authors:  H A Robertson; A D Carlson
Journal:  J Exp Zool       Date:  1976-01

9.  Effect of drugs on luminescence in larval fireflies.

Authors:  A D Carlson
Journal:  J Exp Biol       Date:  1968-08       Impact factor: 3.312

10.  Common inhibitory motoneurones in insects.

Authors:  K G Pearson; S J Bergman
Journal:  J Exp Biol       Date:  1969-04       Impact factor: 3.312

View more
  39 in total

Review 1.  Insect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors.

Authors:  Peter D Evans; Braudel Maqueira
Journal:  Invert Neurosci       Date:  2005-10-24

2.  Stimulation of blowfly feeding behavior by octopaminergic drugs.

Authors:  T F Long; L L Murdock
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

3.  Octopamine receptors in the honey bee and locust nervous system: pharmacological similarities between homologous receptors of distantly related species.

Authors:  J Degen; M Gewecke; T Roeder
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Characterization of octopamine-sensitive adenylate cyclase: elucidation of a class of potent and selective octopamine-2 receptor agonists with toxic effects in insects.

Authors:  J A Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Effects of biogenic amines and adrenergic drugs on oviposition in the cattle tick Boophilus: evidence for octopaminergic innervation of the oviduct.

Authors:  T F Booth
Journal:  Exp Appl Acarol       Date:  1989-09       Impact factor: 2.132

6.  Innervation and neural regulation of the sex pheromone gland in female Heliothis moths.

Authors:  T A Christensen; H Itagaki; P E Teal; R D Jasensky; J H Tumlinson; J G Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Efferent neurotransmission of circadian rhythms in Limulus lateral eye. II. Intracellular recordings in vitro.

Authors:  L Kass; J L Pelletier; G H Renninger; R B Barlow
Journal:  J Comp Physiol A       Date:  1988-11       Impact factor: 1.836

Review 8.  Binding sites for brain trace amines.

Authors:  T V Nguyen; A V Juorio
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

Review 9.  Octopamine-mediated neuromodulation of insect senses.

Authors:  Tahira Farooqui
Journal:  Neurochem Res       Date:  2007-05-05       Impact factor: 3.996

10.  Pharmacology of the octopamine receptor from locust central nervous tissue (OAR3).

Authors:  T Roeder
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.